← Leaderboards
Lorne J Hofseth
University Of South Carolina At Columbia
$6,260,808
Attributed
$10,578,891
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,578,891 · 13
By mechanism
R01$3,757,616 · 2
U01$3,558,479 · 1
P01$1,635,476 · 1
P20$1,184,975 · 6
R03$442,345 · 3
Top collaborators
- Elizabeth Angela Murphy15 shared
- James R Hebert5 shared
- Paul R Thompson5 shared
- Charles D. Smith2 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Elizabeth Angela Murphy$6,337,319
- Narendra P Singh$5,323,240
- Michael Wargovich$3,402,862
- Ehsan Jabbarzadeh$562,218
- Brooke Bullard$38,353
Others in their field
Top investigators on “Colon Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$175,335,637
- Norman Wolmark · Nsabp Foundation, Inc.$48,722,384
- Robert J Coffey · Vanderbilt University$27,051,989
- Sanford D Markowitz · Case Western Reserve University$24,708,814
- Judith A James · Oklahoma Medical Research Foundation$20,921,391
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$20,805,164
Research focus
Colon CarcinomaIn VivoInflammatoryColitisMalignant NeoplasmsInflammatory Bowel DiseasesAnti-Inflammatory AgentsAffectUlcerative ColitisCellsS DiseaseConventional TherapyMediatingCrohn&AposMouse ModelChronicInflammationPreventAmericanPropertyApoptosisMacrophageMolecularPathway Interactions
Grant awards (38)
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer$1,116,364
U01 · FY2025 · CA
CLINTRUSC_PD Core$329,507
P20 · FY2025 · GM · contact PI
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer$20,118
U01 · FY2025 · CA
CLINTRUSC_PD Core$334,578
P20 · FY2024 · GM · contact PI
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$323,796
R01 · FY2024 · CA · contact PI
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$153,059
R01 · FY2024 · CA · contact PI
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer$135,919
U01 · FY2024 · CA
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer - admin supplement$64,828
U01 · FY2024 · CA
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer$1,104,672
U01 · FY2023 · CA
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$334,021
R01 · FY2023 · CA · contact PI
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$157,894
R01 · FY2023 · CA · contact PI
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer$1,116,578
U01 · FY2022 · CA
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$334,021
R01 · FY2022 · CA · contact PI
Administrative Supplement to Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent color cancer$91,228
R01 · FY2022 · CA · contact PI
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$52,017
R01 · FY2022 · CA · contact PI
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$340,838
R01 · FY2021 · CA · contact PI
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer$340,838
R01 · FY2020 · CA · contact PI
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp$340,470
P01 · FY2018 · AT · contact PI
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp$354,394
P01 · FY2017 · AT · contact PI
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp$272,354
P01 · FY2016 · AT · contact PI
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp$329,404
P01 · FY2015 · AT · contact PI
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer$327,269
R01 · FY2015 · CA · contact PI
Epigenetic regulation of Nrf2 signaling pathway in American Ginseng-mediated supp$338,854
P01 · FY2014 · AT · contact PI
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer$317,451
R01 · FY2014 · CA · contact PI
Colon cancer chemoprevention by the anti-inflammatory drug, Quinacrine$70,325
R03 · FY2014 · CA · contact PI
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer$307,633
R01 · FY2013 · CA · contact PI
Colon cancer chemoprevention by the anti-inflammatory drug, Quinacrine$72,500
R03 · FY2013 · CA · contact PI
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer$331,968
R01 · FY2012 · CA · contact PI
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon Cancer$345,583
R01 · FY2011 · CA · contact PI
Colon Cancer Chemoprevention by Dietary Resveratrol$72,000
R03 · FY2010 · CA · contact PI
Sphingosine Kinase as a Target for Cancer Chemoprevention$74,909
R03 · FY2009 · CA · contact PI
Colon Cancer Chemoprevention by Dietary Resveratrol$72,000
R03 · FY2009 · CA · contact PI
INTERVENTION OF AUTOIMMUNE DISEASES BY A NOVEL ANTI-INFLAMMATORY MOLECULE$37,049
P20 · FY2009 · RR · contact PI
NITRIC OXIDE DRIVES RETINOBLASTOMA PATHWAY CHANGES IN INFLAMMATION AND CANCER$177,234
P20 · FY2008 · RR · contact PI
Sphingosine Kinase as a Target for Cancer Chemoprevention$80,611
R03 · FY2008 · CA · contact PI
RETINOBLASTOMA GENE IN INFLAMMATION AND CANCER$120,918
P20 · FY2007 · RR · contact PI
COBRE: USC: RETINOBLASTOMA GENE IN INFLAMMATION AND CANCER$97,931
P20 · FY2006 · RR · contact PI
COBRE: USC: RETINOBLASTOMA GENE IN INFLAMMATION AND CANCER$87,758
P20 · FY2005 · RR